Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical...
Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Brain degeneration and damage is difficult to cure due to the limited endogenous repair capability of the central nervous system. Furthermore, drug development for treatment of diseases of the central nervous system remains a major challenge. However, it now appears that using human pluripotent stem cell‐derived neural cells to replace degenerating...
Alternative Titles
Full title
Neuronal cell‐based medicines from pluripotent stem cells: Development, production, and preclinical assessment
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ecec7af52d0c405ab8a09e86e73ae420
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ecec7af52d0c405ab8a09e86e73ae420
Other Identifiers
ISSN
2157-6564,2157-6580
E-ISSN
2157-6580
DOI
10.1002/sctm.20-0522
